Day One Biopharmaceuticals Inc (DAWN)
13.72
+0.38
(+2.85%)
USD |
NASDAQ |
Nov 22, 16:00
15.14
+1.42
(+10.35%)
After-Hours: 20:00
Day One Biopharmaceuticals Shareholders Equity (Quarterly): 555.46M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 555.46M |
June 30, 2024 | 306.73M |
March 31, 2024 | 296.81M |
December 31, 2023 | 346.54M |
September 30, 2023 | 389.63M |
June 30, 2023 | 426.05M |
March 31, 2023 | 300.42M |
December 31, 2022 | 332.04M |
Date | Value |
---|---|
September 30, 2022 | 363.08M |
June 30, 2022 | 390.63M |
March 31, 2022 | 259.60M |
December 31, 2021 | 281.15M |
September 30, 2021 | 297.67M |
June 30, 2021 | 311.76M |
March 31, 2021 | -68.85M |
December 31, 2020 | -54.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-68.85M
Minimum
Mar 2021
555.46M
Maximum
Sep 2024
295.91M
Average
309.25M
Median
Shareholders Equity (Quarterly) Benchmarks
Perspective Therapeutics Inc | 328.47M |
Electromed Inc | 41.49M |
Xtant Medical Holdings Inc | 45.72M |
Myomo Inc | 9.292M |
Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 600.81M |
Total Liabilities (Quarterly) | 45.34M |
Current Ratio | 14.62 |